Ulrich Strych

Texas Children's Hospital — United States

Medicine · Health Sciences

41h-index5.8kcitations133works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(41), Research on Leishmaniasis Studies(17), vaccines and immunoinformatics approaches(16), Parasites and Host Interactions(15), Trypanosoma species research and implications(15)

Publications133 total

Develop a durable, memory-driven, CspZ-targeting Lyme disease vaccine by rationale adjuvant selection
2026Open Access
Heterologous prime-pull mucosal vaccination with an adjuvanted RBD vaccine elicits robust IgA production and protects against SARS-CoV-2
Frontiers in Immunology·2025Open Access
Characteristic profiling of CHO-cell expressed MERS-CoV RBD-Fc
International Journal of Biological Macromolecules·2025
Mechanistic insights into the structure-based design of a CspZ-targeting Lyme disease vaccine
Nature Communications·2025· 4 citedOpen Access
The Current and Future Burden of Long COVID in the United States
The Journal of Infectious Diseases·2025· 19 citedOpen Access
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization
Frontiers in Immunology·2024· 3 citedOpen Access
Mechanistic insights into structure-based design of a Lyme disease subunit vaccine
2024Open Access
Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins
Viruses·2024· 1 citedOpen Access
A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudoviruses
npj Vaccines·2024· 4 citedOpen Access
The zebrafish as a potential model for vaccine and adjuvant development
Expert Review of Vaccines·2024· 7 citedOpen Access
What Is the Economic Benefit of Annual COVID-19 Vaccination From the Adult Individual Perspective?
The Journal of Infectious Diseases·2024· 5 citedOpen Access
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease
ACS Applied Materials & Interfaces·2024· 17 citedOpen Access
Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine
Frontiers in Drug Delivery·2024· 1 citedOpen Access
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study
EClinicalMedicine·2024· 18 citedOpen Access
Biophysical and biochemical characterization of a recombinant Lyme disease vaccine antigen, CspZ-YA
International Journal of Biological Macromolecules·2024· 5 cited
Generation and Characterization of In Vitro Transcribed mRNA
Methods in molecular biology·2024
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
Vaccines·2023· 10 citedOpen Access
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
Preprints.org·2023· 1 citedOpen Access
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
Preprints.org·2023· 1 citedOpen Access
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
Preprints.org·2023· 2 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Peter J. Hotez(32), María Elena Bottazzi(31), Wen‐Hsiang Chen(14), Jeroen Pollet(13), Portia M. Gillespie(9), Bin Zhan(8), Junfei Wei(8), Zhuyun Liu(8), Kurt L. Krause(7), Richard C. Willson(6), Leroy Versteeg(6), Brian Keegan(6), Jungsoon Lee(6), Michael J. Benedik(6), Coreen M. Beaumier(5), Rakesh Adhikari(5), Cristina Poveda(5), Tara Hayward(4), Amadeo B. Biter(4), Christopher A. Seid(4)